Description: Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Home Page: izocorp.com
800-15355 24th Avenue
Surrey,
BC
V4A 2H9
Canada
Phone:
833-496-2677
Officers
| Name | Title |
|---|---|
| Mr. Robert Louis Thast | Founder, Interim CEO & Chairman |
| Dr. Younes Achkire Ph.D. | Executive VP of Product Engineering & COO |
| Mr. Ali Reza Sodagar | Legal Advisor & Independent Director |
| Ms. Jaclyn Thast | Operations Manager & Corporate Secretary |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 115.8079 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | April |
| Full Time Employees: | 0 |